by John Conrad | May 29, 2024 | NewsBrief
Early drug development requires critical decisions under severe time and cost pressure. Data comes from multiple parallel activities and identifying possible key risks can be a challenge for companies with limited resources, a position many small biotechs find...
by John Conrad | Mar 13, 2020 | Policy News
From BIO: The Securities and Exchange Commission (SEC) has adopted regulatory changes to provide small public companies with a temporary exemption from Sarbanes-Oxley 404(b) compliance. 404(b) requires public companies to report on the internal controls they have in...
by John Conrad | Nov 11, 2019 | Member News
Cyclopure based out of the Illinois Science + Technology Park in Skokie, Illinois was named in C&EN’s annual list of startups to watch. CycloPure is a materials science company and a leader in water purification technologies. The company’s line of DEXSORB...
